STOCK TITAN

T3 Defense (NASDAQ: DFNS) sinks into negative equity as Nasdaq sets 45-day deadline

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

T3 Defense Inc. (DFNS) reported that on August 20, 2026 it received a notice from Nasdaq’s Listing Qualifications Staff that it is not in compliance with Nasdaq Listing Rule 5450(b)(1)(A), which requires minimum stockholders’ equity of $10,000,000 for continued listing on the Nasdaq Global Market.

Based on its Form 10-Q for the period ended June 30, 2026, T3 Defense’s stockholders’ equity fell from $42,523,000 as of March 31, 2026 to negative $19,659,000 as of June 30, 2026. Management attributes this swing primarily to outstanding warrants from a $10 million February 2026 private placement, whose entire proceeds were allocated to a Common Warrants liability.

For the six and three months ended June 30, 2026, the company recognized a loss from change in fair value of this Common Warrant liability of approximately $98,958 thousand and $80,884 thousand, respectively, as the liability increased from about $25,429 thousand at initial recognition to $124,387 thousand as of June 30, 2026 and $43,503 thousand as of March 31, 2026. T3 Defense has 45 days (until October 5, 2026) to submit a compliance plan. The notice has no immediate effect on trading, and DFNS will continue to trade on the Nasdaq Global Market while the company evaluates options and prepares its plan, though a delisting determination could follow if compliance is not regained.

Positive

  • None.

Negative

  • Noncompliance with Nasdaq equity rule and delisting risk: T3 Defense no longer meets the $10,000,000 minimum stockholders’ equity required by Nasdaq Listing Rule 5450(b)(1)(A), triggering a formal deficiency notice and potential future delisting if a compliance plan is not accepted or successful.
  • Sharp deterioration to negative equity: Stockholders’ equity moved from $42,523,000 at March 31, 2026 to negative $19,659,000 at June 30, 2026, signaling a materially weakened balance sheet position.
  • Large loss from warrant fair value changes: The company recorded losses from change in fair value of Common Warrant liability of about $98,958 thousand for six months and $80,884 thousand for three months ended June 30, 2026, driving a significant negative impact on reported equity.

Filing Explained

If Nasdaq accepts the compliance plan, its staff may grant up to 180 calendar days from August 20, 2026 to evidence compliance; if it does not, a hearing request would stay delisting action.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Minimum stockholders’ equity requirement $10,000,000 Required by Nasdaq Listing Rule 5450(b)(1)(A) for continued listing on the Nasdaq Global Market
Stockholders’ equity as of March 31, 2026 $42,523,000 Reported stockholders’ equity before subsequent decline below Nasdaq requirement
Stockholders’ equity as of June 30, 2026 -$19,659,000 Reported negative stockholders’ equity triggering Nasdaq noncompliance notice
Private placement amount $10,000,000 February 2026 private placement whose proceeds were allocated to Common Warrants liability
Loss from change in fair value of Common Warrant liability (six months) $98,958 thousand For the six months ended June 30, 2026
Loss from change in fair value of Common Warrant liability (three months) $80,884 thousand For the three months ended June 30, 2026
Common Warrant liability at initial recognition $25,429 thousand Initial fair value of Common Warrant liability
Common Warrant liability as of June 30, 2026 $124,387 thousand Fair value of Common Warrant liability at June 30, 2026
Nasdaq Listing Rule 5450(b)(1)(A) regulatory
"not in compliance with the minimum stockholders' equity requirement set forth in Nasdaq Listing Rule 5450(b)(1)(A)"
stockholders' equity financial
"minimum stockholders' equity of $10,000,000 and reported negative $19,659,000 as of June 30, 2026"
Stockholders' equity is the portion of a company's assets that belongs to its owners after all debts and obligations are paid; think of it as the value left for shareholders if the company sold everything and paid off what it owes. Investors watch it because it shows the company's net worth, indicates how much of growth is funded by owners versus debt, and helps assess financial health and the potential for future dividends or stock value increases — like the equity in a house after the mortgage is settled.
Common Warrant liability financial
"recognized a loss from the change in fair value of the Common Warrant liability of approximately $98,958 thousand"
private placement financial
"outstanding warrants associated with the $10 million February 2026 private placement"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
delisting determination regulatory
"the Staff would be required to issue a delisting determination"
A delisting determination is a formal decision by a stock exchange or regulator to remove a company’s shares from the official trading list, usually after the company fails to meet rules such as filing reports, maintaining a minimum share price, or staying solvent. It matters to investors because removal reduces or eliminates easy ways to buy or sell the shares, can sharply lower their value, and forces holders to trade in smaller, riskier markets — like having to sell a car at a neighborhood garage sale instead of a busy dealership.
Nasdaq Hearings Panel regulatory
"The Company would at that time be entitled to request a hearing before a Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.

FAQ

Why did T3 Defense Inc. (DFNS) receive a notice from Nasdaq on August 20, 2026?

T3 Defense received a Nasdaq notice because it is not in compliance with Nasdaq Listing Rule 5450(b)(1)(A), which requires minimum stockholders’ equity of $10,000,000. Its June 30, 2026 Form 10-Q showed stockholders’ equity below this threshold.

What are T3 Defense Inc. (DFNS)’s recent stockholders’ equity figures?

T3 Defense reported stockholders’ equity of $42,523,000 as of March 31, 2026, which declined to negative $19,659,000 as of June 30, 2026, causing it to fall below Nasdaq’s minimum equity requirement.

What caused the large swing in T3 Defense Inc. (DFNS)’s stockholders’ equity?

Management believes the swing is mainly due to outstanding warrants from a $10 million February 2026 private placement. All proceeds were allocated to a Common Warrants liability, whose fair value increased sharply, producing large losses and reducing reported equity.

How large is the loss from T3 Defense Inc. (DFNS)’s Common Warrant liability change?

For the six and three months ended June 30, 2026, T3 Defense recognized losses from change in fair value of the Common Warrant liability of approximately $98,958 thousand and $80,884 thousand, respectively, reflecting a substantial increase in the liability’s fair value.

Does the Nasdaq notice immediately affect trading of T3 Defense Inc. (DFNS) stock?

No. The company states the notification has no immediate effect on the listing or trading of its common stock. DFNS will continue to trade on the Nasdaq Global Market while it submits and pursues a plan to regain compliance.

What is the timeline for T3 Defense Inc. (DFNS) to regain Nasdaq compliance?

T3 Defense has 45 calendar days, until October 5, 2026, to submit a plan to regain compliance. If accepted, Nasdaq Staff may grant up to an additional 180 calendar days from the notification date to evidence compliance.

What happens if T3 Defense Inc. (DFNS) cannot regain compliance with Nasdaq’s rule?

If Nasdaq Staff does not accept the plan or T3 Defense does not regain compliance within any extension, Staff would issue a delisting determination. The company could then request a hearing before a Nasdaq Hearings Panel, which would stay any delisting action while the hearing is pending.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001787518 0001787518 2026-08-20 2026-08-20 0001787518 DFNS:CommonStock0.0001ParValuePerShareMember 2026-08-20 2026-08-20 0001787518 DFNS:WarrantsEachWarrantExercisableForOneShareOfCommonStockFor11500.00PerShareMember 2026-08-20 2026-08-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 20, 2026

 

T3 DEFENSE INC.
(Exact name of registrant as specified in its charter)

 

Delaware   001-39341   38-3912845
(State or other jurisdiction of
incorporation or organization)
  (Commission File Number)   (IRS Employer
Identification Number)

 

575 Fifth Avenue, 14th Floor

New York, New York 10017

(Address of principal executive offices)

 

212-791-4663

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   DFNS   The Nasdaq Stock Market LLC
         
Warrants, each warrant exercisable for one Share of Common Stock for $11,500.00 per share   DFNSW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 

 

 

Item 3.01   Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On August 20, 2026, T3 Defense Inc., a Delaware corporation (the “Company”) received a notice (the “Notification Letter”) from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market, LLC ("Nasdaq") notifying the Company that it is not in compliance with the minimum stockholders' equity requirement set forth in Nasdaq Listing Rule 5450(b)(1)(A) for continued listing on The Nasdaq Global Market, and, as of the date of the Notification Letter, the Company did not meet the alternatives of market value of listed securities or net income from continuing operations (together with the stockholders’ equity requirement, the “Listing Rule”). Nasdaq Listing Rule 5450(b)(1)(A) requires listed securities to maintain a minimum stockholders' equity of $10,000,000. Based on the stockholders' equity reported in the Form 10-Q for the period ended June 30, 2026, the Company no longer meets the minimum stockholders' equity requirement. 

 

Management believes that the reduction in stockholders' equity of $42,523,000 as of March 31, 2026 to negative $19,659,000 as of June 30, 2026 is a result of the outstanding warrants associated with the $10 million February 2026 private placement.

 

The entire placement proceeds were allocated to the Common Warrants liability. Accordingly, for the six and three months ended June 30, 2026, the Company recognized a loss from the change in fair value of the Common Warrant liability of approximately $98,958 thousand and $80,884 thousand, respectively, representing the increase in fair value from approximately $25,429 thousand at initial recognition to approximately $124,387 thousand as of June 30, 2026 and $43,503 thousand as of March 31, 2026.

 

The Notification Letter provides that the Company has 45 calendar days, or until October 5, 2026, to submit a plan to regain compliance. If the plan is accepted, the Staff may grant the Company an extension period of up to 180 calendar days from the date of the Notification Letter to evidence compliance. If Nasdaq does not accept the plan, the Company may appeal the decision to a hearings panel.

 

The Notification Letter has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Global Market and, at this time, the common stock will continue to trade on The Nasdaq Global Market under the symbol “DFNS.” The Company intends to timely submit a plan to regain compliance. The Company is currently evaluating its options for regaining compliance. There can be no assurance that the Staff will accept the Company’s plan to regain compliance with the Listing Rule or, if accepted, that the Company will evidence compliance with the Listing Rule during any extension period that the Staff may grant. If the Staff does not accept the Company’s plan or if the Company is unable to regain compliance within any extension period granted by the Staff, the Staff would be required to issue a delisting determination. The Company would at that time be entitled to request a hearing before a Nasdaq Hearings Panel to present its plan to regain compliance and to request a further extension period to regain compliance. The request for a hearing would stay any delisting action by the Staff.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  T3 DEFENSE INC.
     
Date: August 20, 2026 By: /s/ Menachem Shalom
  Name:  Menachem Shalom
  Title: Chief Executive Officer

 

 

2

 

 

 

Filing Exhibits & Attachments

4 documents